Latest FDA News | Page 5

Galderma Receives U.S. FDA Approval for Nemluvio® (nemolizumab) for Adult Patients Living With Prurigo Nodularis
FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face
What Went Wrong In 2022 Baby Formula Crisis?
Infectious diseases spike when kids return to school − here’s what you can do about it
How a Legal Loophole Allows Unsafe Ingredients in U.S. Foods
Study Finds Reliable Performance For Wireless Pacemaker
Psilocybin legislation is helping psychedelic drugs make a comeback – a drug researcher explains the challenges they face
Retaining flavor while removing caffeine − a chemist explains the chemistry behind decaf coffee
Worried about the health effects of the sugar in your breakfast cereal? Little has changed since the days of ‘Unfrosted,’ the Pop-Tarts movie
Neuren secures Rare Paediatric Disease Designation from FDA
The long – and strange – history of testing menstrual blood for health conditions
Nutrition Facts labels have a complicated legacy – a historian explains the science and politics of translating food into information
Dimerix Awarded Bioshares Excellence Award
Oticon Medical’s Sentio(TM) System Receives Regulatory Clearance in the US
Orthocell receives regulatory approval to commence sales of Striate+ in Canada
Dr James Campbell Appointed AusBiotech Chair
FDA authorized the sale of menthol-flavored e-cigarettes – a health policy expert explains how the benefits may outweigh the risks
Ketamine in tablet form shown to reduce symptoms of severe depression
Ketamine slow-release tablet reduces symptoms of severe depression: clinical trial
Strengthening research ethics in clinical trials in Rwanda
No more recreational vaping for Australians. From October, vapes will be sold over the counter at pharmacies
Medical Device Regulation Changes
Groundbreaking cancer treatment may trigger more cancer – but here’s why you shouldn’t worry
WHO and United States Food and Drug Administration extend the CRP-Lite pilot
US FDA grants rare paediatric disease designation to Race Oncology’s RC220 bisantrene
Oral nicotine pouches deliver lower levels of toxic substances than smoking – but that doesn’t mean they’re safe
Supreme Court unanimously concludes that anti-abortion groups have no standing to challenge access to mifepristone – but the drug likely faces more court challenges
Aussie innovators recognised at CSIRO’s ON Accelerate 8 Showcase
Germans Trias i Pujol Hospital in Spain Launches Telehealth and Remote Patient Management Program Using Masimo W1® Medical Watches and Radius VSM(TM)…
Progress update on the WHO-US FDA collaborative project on the review and use of online repository for difficult-to-treat infections
Dimerix announces Middle East license agreement for DMX-200
Largest number of regulatory agencies for medical products approved as WHO Listed Authorities
Alcohol use disorder can be treated with an array of medications – but few people have heard of them
‘They call us the fatherless ones’: the trauma of families devastated by the infected blood scandal will last for generations
Sleep wrinkles are real. Here’s how they leave their mark
Opyl expands coverage TrialKey of clinical trial prediction and design optimisation
FivepHusion announces ethics approval of Phase 1b trial of deflexifol as first-line treatment
How bird flu virus fragments get into milk sold in stores, and what the spread of H5N1 in cows means for the…
US drugs regulator gives LSD ‘breakthrough’ status for treating anxiety – why this is so significant
The UK plans to phase out smoking. What does this new law mean for tobacco control in Australia?
Telix Pharmaceuticals records another quarter of strong revenue growth
Firebrick Pharma launches Nasodine in the United States
Telix’s TLX101-CDx granted fast track designation by US FDA
Synthetic Platelets Stanch Bleeding, Promote Healing in Animal Models
Leading US Cardiologist Visits Heart Research Institute
A natural deception: 3 marketing myths the supplement industry wants you to swallow
Optiscan Imaging announces the appointment of US clinical and regulatory heads
The rise of Ozempic: how surprise discoveries and lizard venom led to a new class of weight-loss drugs